Influence of Pharmaceutical Promotional Tools on Doctors' Prescribing Behaviour: An Exploratory Study

Authors

  •   Neeti Kasliwal Assistant Professor, Faculty of Management Studies, Banasthali Vidyapith, C-62, Sarojini Marg, C-Scheme, Jaipur, Rajasthan
  •   Ipshita Bansal Professor & Dean, Faculty of Commerce and Management Studies, Bhagat Phoolsingh Womens' University, Khanpur, Kalan, Sonepat - 131 305 , Haryana

DOI:

https://doi.org/10.17010/ijom/2013/v43/i8/36319

Keywords:

Pharmaceutical Promotions, Pharmaceutical Marketing, Doctors, Prescribing Behaviour, Prescribing Habits, Medical Representatives.

Abstract

The healthcare industry in general, and the prescription drug industry, in particular, employs an unusual combination of marketing and promotional efforts to influence the doctors who write the prescriptions that determine which drugs (brands) will be used by the ultimate consumer (patient). The involvement of doctors as key decision makers is the reason that they are the focus of most promotional efforts of pharmaceutical companies. Thus, influencing the doctor is a key to the pharmaceutical sales, and the pharmaceutical companies are spending a lot of money on marketing their products to the doctors. The present study examines the impact of promotional tools on doctors' prescribing behaviour. A total of 431 respondents were selected through convenience sampling from different cities of Rajasthan. The results show that the promotional factors which were found to be more influencing were the activities of the MR (medical representative), their rapport with the doctors, their personality traits, and the drug samples, leaflets, and brochures given by the MRs to the doctors. The findings are discussed in the light of past studies, and future directions for research are outlined.

Downloads

Download data is not yet available.

Downloads

Published

2013-09-29

How to Cite

Kasliwal, N., & Bansal, I. (2013). Influence of Pharmaceutical Promotional Tools on Doctors’ Prescribing Behaviour: An Exploratory Study. Indian Journal of Marketing, 43(8), 23–34. https://doi.org/10.17010/ijom/2013/v43/i8/36319

Issue

Volume 43, Issue 8, August 2013

Section

Articles
Crossref
Scopus
Google Scholar
Europe PMC

References

Alghasham, A. A. (2009). “Generic Drug Prescribing in Central Saudi Arabia: Perceptions and Attitudes of Physicians.†Annals of Saudi Medicine, 29 (1), 24-29, DOI: 10.4103/0256-4947.51819.

Armstrong, D., Reyburn, H., & Jones, R. (1996). “A Study of General Practitioners' Reasons for Changing their Prescribing Behavior.†British Medical Journal, 312 (7036), 949-952, DOI: http://dx.doi.org/10.1136/bmj.312.7036.949.

Arora, U., & Taneja, G. (2006). “An Analytical Study of Physicians Behavior towards Marketing of Pharmaceutical Products.†Indian Journal of Marketing, 36 (11), 10-13.

Balhara,Y.P.S., Mathur, S., & Anand, N.(2012). “A Study of Attitude and Knowledge of the Psychiatry Doctors towards Clinician-Pharmaceutical Industry Interaction.†Indian Journal Psychological Medicine, 34 (1), 61-65, DOI: 10.4103/0253-7176.96162.

Bauer, R. A., & Wortzel, L. H. (1966). “Doctor's Choice: The Physician and His Sources of Information about Drugs.†Journal of Marketing Research, 3 (1), 40-47.

Bhardwaj, P., & Mazumdar, P. (2011). “Buying Behavioral Pattern of Ethical and Generic Drugs in Western India: An Empirical Investigation.†International Journal of Business Innovation and Research, 5 (1), 75-88, DOI: 10.1504/IJBIR.2011.037258.

Bhatt, A. D. (1993). “Drug Promotion and Doctor: A Relationship under Change?†Journal of Postgraduate Medicine, 39 (3), 120-123, PMID:0008051638.

Cardarelli, R., Licciardone, J., & Taylor, L. G. (2006). “A Cross Sectional Evidence Based Review of Pharmaceutical Promotional Marketing Brochures and their Underlying Studies: Is what they tell us Important and True?†BMC Family Practice, 7 (1), 7-13, DOI: 10.1186/1471-2296-7-13.

Caudill, T.S., Johnson, M.S., Rich, E.C., & McKinney, W.P. (1996). “Physicians, Pharmaceutical Sales Representatives, and the Cost of Prescribing.†Archives of Family Medicine, 5(4), 201 - 206.

Chew, L.D., O'Young, T.S., Hazlet, T.K., Bradley, K.A., Maynard, C., & Lessler, D.S. (2000). “A Physician Survey of the Effect of Drug Sample Availability on Physicians' Behavior.†Journal of General Internal Medicine, 15 (7), 478-83.

Ching, A., & Ishihara, M. (2010). "The Effects of Detailing on Prescribing Decisions under Quality Uncertainty." Quantitative Marketing and Economics, 8 (2), 123-165, Retrieved from SSRN, http://ssrn.com/abstract=1010179

Chintagunta, P. K., & Desiraju, R. (2005)."Strategic Pricing and Detailing Behavior in International Markets.†Marketing Science, 24 (1), 67 - 80, DOI :10.1287/mksc.1030.0029.

Denig, P., Witteman, C.L.M., & Schouten, H.W. (2002). “Scope and Nature of Prescribing Decisions made by General Practitioners.†Quality and Safety in Health Care, 11(2), 137-143. DOI:10.1371/JOURNAL.PONE.0006350.

Gibbons, R. V., Landry, F., J., Blouch, D. L., Jones, D. L. Williams, F. K., Lucey, C., R., & Kurt, K. (1998). “A Comparison of Physicians' and Patients' Attitudes towards Pharmaceutical Industry Gifts.†Journal of General Internal Medicine, 13 (3),151-154, DOI : 10.1046/j.1525-1497.1998.00048.x.

Girdharwal, N. (2007). “A Study of Physicians' Behavior towards Marketing of Pharmaceutical Products: A Case Study of Indian Market.†Retrieved from http://www.pharmainfo.net/reviews/study-physicians-behaviour-toward-marketing-pharmaceutical-products-case-study-indian-market

Gönül, F. F., Carter, F., Petrova, E., & Srinivasan, K. (2001). “Promotion of Prescription Drugs and Its Impact on Physicians' Choice Behavior.†Journal of Marketing, 65 (3), 79 - 90.

Grande, D. (2010). “Limiting the Influence of Pharmaceutical Industry Gifts on Physicians: Self Regulation or Government Intervention.†Journal of General Internal Medicine, 25(1), 79-83.

Henry, D. (2010). “Doctors and Drug Companies: Still Cozy after all these Years.†PLOS Medicine, 7 (11): e1000359. DOI:10.1371/journal.pmed.1000359 .

Hopper, J.A., Speece, M. W., & Musial, J. L. (1997). “Effects of an Educational Intervention on Residents' Knowledge and Attitudes towards Interactions with Pharmaceutical Representatives.†Journal of General Internal Medicine, 12(10), 639-642.

Ijoma, U., Onwuekwe, I., Onodugo, O., Aguwa, E., Ejim, E., Onyedum, C., ...Ugwuonah, G. (2009). “Effect of Promotional Strategies of Pharmaceutical Companies on Doctors' Prescription Pattern in South East Nigeria.†TAF Preventive Medicine Bulletin, 9 (1), 1-6.

Jain, S., & Saxena, K. (2011). “Lifestyle and General Medicines: A Study of Promotional-Mix Strategies in India.†Journal of Medical Marketing, 11 (2), 119-126, DOI: 10.1057/jmm.2010.35.

Kalantri, S. P. (2004). “Drug Industry and Medical Conferences.†Indian Journal of Anaesthesia, 48 (1), 28-30.

Lexchin, J. (1993). “Interactions between Physicians and the Pharmaceutical Industry: What does the Literature Say?†Canadian Medical Association Journal, 149 (10), 1401-1407.

Madhavan, S., Amonkar, M.M., Elliott, D., Burke, K., & Gore, P. (1997). “The Gift Relationship between Pharmaceutical Companies and Physicians: An Exploratory Survey of Physicians.†Journal of Clinical Pharmacy and Therapeutics, 22 (3), 207 - 215.

Manchanda, P., & Chintagunta, P. K. (2004). “Responsiveness of Physician Prescription Behaviour to Salesforce Effort: An Individual Level Analysis.†Market Letters, 15 (2-3), 129 - 145.

McGettigan, P., Golden, J., Fryer, J., Chan, R., & Feely, J. (2001). “Prescribers Prefer People: The Sources of Information Used by Doctors for Prescribing Suggest that the Medium is More Important than the Message.†British Journal of Clinical Pharmacology, 51(2), 184-189.

Mehta, P.N. (2000). “Drug Makers and Continuing Medical Education.†Indian Pediatrics, 37(6), 626-630.

Mohanty, B.K., Aswini, M., Hasamnis, A.A., Patil, S.S., Murty, K.S.N., & Jena, S.K. (2010). “Prescription Pattern in the Department of Medicine of a Tertiary Care Hospital in South India.†Journal of Clinical and Diagnostic Research, 4 (1), 2047-2051.

Morgan, M.A., Dana, J., Loewenstein, G., Zinberg, S., & Schulkin, J. (2006). “Interactions of Doctors with the Pharmaceutical Industry.†Journal of Medical Ethics, 32 (10), 559 - 563.

Mujirers, P.E., Grol, R.P., Sijbrandij, J., Janknegt, R., & Knottnerus, J.A. (2005). “Differences in Prescribing between GPs: Impact of the Cooperation with Pharmacists and Impact of Visits from Pharmaceutical Industry Representatives.†Family Practice , 22 (6), 624-630.

Narayan, A. (2011, September 8). “Welcome to India, the Land of the Drug Reps.†Bloomberg Businessweek Magazine, Retrieved from http://www.businessweek.com/welcome-to-india-the-land-of-the drug-reps

Narayanan, S., Manchanda, P., & Chintagunta, P.K. (2005). “Temporal Differences in the Role of Marketing Communication in New Product Categories.†Journal of Marketing Research, 42(3), 278 - 290, DOI: http://dx.doi.org/10.1509/jmkr.2005.42.3.278.

Othman, N., Vitry, A., & Roughead, E. E. (2009). “Quality of Pharmaceutical Advertisements in Medical Journals: A Systematic Review.†PLoS One, 4 (7),e6350.

Pharmaceutical Drug Manufacturers (n.d.). “Indian Pharmaceutical Industry.†Retrieved from http://www.pharmaceutical-drug-manufacturers.com/pharmaceutical-industry

Prosser, H., & Walley, T. (2003). “Understanding Why GP's See Pharmaceutical Representatives: A Qualitative Interview Study.†British Journal of General Practice, 53 (489), 305 - 311.

Rohra, D.K., Gilani, A.H., Memon, I.K., Perven, G., Khan, M.T., Zafar, H., & Kumar, R. (2006). “Critical Evaluation of the Claims Made by Pharmaceutical Companies in Drug Promotional Material in Pakistan.†Journal of Pharma and Pharmaceutical Science, 9 (1), 50-59 .

Saito, S., Mukohara, K., & Bito, S. (2010). “Japanese Practicing Physicians' Relationships with Pharmaceutical Representatives: A National Survey.†PLoS ONE 5 (8): e12193. doi:10.1371/journal.pone.0012193.

Sbarbaro, J. A. (2001). “Can We Influence Prescribing Patterns?†Clinical Infectious Diseases, 33 (3), S240-S244. DOI: 10.1086/321856.

Shankar, P. R., Singh, K. K., & Piryani, R. M. (2012). “Knowledge, Attitude and Skills before and after a Module on Pharmaceutical Promotion in a Nepalese Medical School.†BMC Research Notes, 5 (1), 8, DOI: 10.1186/1756-0500-5-8.

Siddiqi, A., Hussain, S., Praveen, G., Malik, F., Yasin, F., Akram, T.S., ...Saeed, T. (2011). “Relevant Influence of Promotional Tools by Pharmaceutical Industry on Prescribing Behaviour of Doctors: A Cross Sectional Survey in Pakistan.†African Journal of Pharmacy and Pharmacology, 5 (13), 1623-1632, DOI: 10.5897/AJPP11.243.

Singh, R. (2008). “Network Connectedness of Pharmaceutical Sales Rep (FLE)-Physician Dyad and Physician Prescription Behavior: A Conceptual Model.†Journal of Medical Marketing: Device, Diagnostic and Pharmaceutical Marketing, 8 (3), 257-268, DOI:10.1057/JMM.2008.14.

Steinman, M., & Baron, B. R. (2007). “Is Continuous Medical Education a Drug Promotion Tool?†Canadian Family Physician, 53 (10), 1650-1653.

Stros, M., Hari, J., & Marriott, J. (2009). “The Relevance of Marketing Activities in the Swiss Prescription Drugs Market: Two Empirical Qualitative Studies.†International Journal Of Pharmaceutical and Healthcare Marketing, 3 (4), 323-346, DOI : 10.1108/17506120911006038.

Stryer, D., & Bero, L. A. (2009). “Characteristics' of Materials Distributed by Pharmaceutical Companies: An Evaluation of Appropriateness.†Journal of General Internal Medicine, 11 (10), 575 - 583.

Taneja, G. (2008). “Impact of Pharmaceutical Industry Promotion Mix on Doctors Prescribing Behaviour.†Asia-Pacific Business Review, 4 (4), 82-95.

Warrier, R., Monaghan, M.S., Anna, M., Huggett, H., & Rich, E. (2010). “Effect of Drug Sample Availability on Physician Prescribing Behavior: A Systematic Review.†Clinical Reviews and Opinions, 2 (4), 41-48.

Watkins, C., Moore, L., Harvey, I., Carthy, P., Robinson, E., & Brawn, R. (2003). “Characteristics of General Practitioners Who Frequently See Drug Industry Representatives: National Cross Sectional Study.†British Medical Journal, 326 (7400), 1178 - 1179, DOI: http://dx.doi.org/10.1136/bmj.326.7400.1178.

Wazana, A. (2000). “Doctors and the Pharmaceutical Industry is a Gift ever just a Gift?†Journal of American Medical Association, 283 (3), 373-380.